SCHEMBL1017726

SCHEMBL1017726

NC(=O)C1=CC=CNC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL30468940 0.98 THRB (0.36)
SCHEMBL22411680 0.98
SCHEMBL17905877 0.75
SCHEMBL29600745 0.70 TP53 (0.31)
SCHEMBL28345684 0.67 TSHR (0.30)
SCHEMBL8333628 0.65
SCHEMBL28952767 0.65 GABRR1 (0.32)
SCHEMBL4658687 0.64
SCHEMBL2718682 0.64
SCHEMBL27658053 0.64

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 326 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4619407-A1 PYRIDONE AND PYRIMIDINONE INHIBITORS OF HEMATOPOIETIC PROGENITOR KINASE 1 Curadev Pharma Ltd (GB) 2025-09-24 EP claimed
US-20250127804-A1 RIBOSE LINKERS AND CONJUGATES THEREOF UNIVERSITY OF SOUTH ALABAMA 2025-04-24 US claimed
US-20240417421-A1 NMN And Derivatives For Its Use In The Treatment Of Depression And/Or Anxiety In Patients Having A Form Of Parkinsonism NUVAMID SA (CH) 2024-12-19 US claimed
EP-4472993-A2 RIBOSE LINKERS AND CONJUGATES THEREOF Elysium Health, Inc. (US) 2024-12-11 EP claimed
CN-118632855-A Ribose linker and conjugates thereof 益力舒健康公司 2024-09-10 CN claimed
WO-2024105363-A1 PYRIDONE AND PYRIMIDINONE INHIBITORS OF HEMATOPOIETIC PROGENITOR KINASE 1 CURADEV PHARMA LTD (GB) 2024-05-23 WO claimed
EP-3762392-B1 THIENOPYRIDINE DERIVATIVES AND PHARMACEUTICAL COMPOSITION COMPRISING SAME WELLMARKER BIO CO LTD (KR) 2024-05-15 EP claimed
WO-2024098042-A2 GROWTH-BASED SELECTION PLATFORM FOR NONCANONICAL COFACTOR OXIDIZING ENZYMES THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2024-05-10 WO claimed
US-20240116971-A1 NMN AND DERIVATIVES FOR ITS USE IN THE TREATMENT OF DEPRESSION AND/OR ANXIETY IN PATIENTS HAVING A FORM OF PARKINSONISM NUVAMID SA (CH) 2024-04-11 US claimed
WO-2023150667-A2 RIBOSE LINKERS AND CONJUGATES THEREOF ELYSIUM HEALTH INC. (US) 2023-08-10 WO claimed
EP-2321299-A2 PYRIDONS AS PDK1 INHIBITORS Boehringer Ingelheim International GmbH (DE) 2011-05-18 EP claimed
EP-2288383-A1 COMBINATIONS VEGF(R) INHIBITORS AND HEPATOCYTE GROWTH FACTOR (C-MET) INHIBITORS FOR THE TREATMENT OF CANCER Amgen, Inc (US) 2011-03-02 EP claimed
EP-2271624-A1 IMINOPYRIDINE DERIVATIVES AND USE THEREOF Takeda Pharmaceutical Company Limited (JP) 2011-01-12 EP claimed
WO-2010126914-A1 PYRIDINONE ANTAGONISTS OF ALPHA-4 INTEGRINS ELAN PHARMACEUTICALS, INC. (US) 2010-11-04 WO claimed
WO-2010007114-A2 NEW CHEMICAL COMPOUNDS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2010-01-21 WO claimed
WO-2010007116-A2 NEW CHEMICAL COMPOUNDS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2010-01-21 WO claimed
WO-2009140549-A1 COMBINATIONS VEGF(R) INHIBITORS AND HEPATOCYTE GROWTH FACTOR (C-MET) INHIBITORS FOR THE TREATMENT OF CANCER AMGEN INC. (US) 2009-11-19 WO claimed
WO-2009131245-A1 IMINOPYRIDINE DERIVATIVES AND USE THEREOF TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2009-10-29 WO claimed
WO-2003057688-A2 OXO OR OXY-PYRIDINE COMPOUNDS AS 5-HT4 RECEPTOR MODULATORS PFIZER JAPAN INC. (JP) 2003-07-17 WO claimed
CN-1034728-A The synthetic method of dimer alkaloid compounds UNIV BRITISH COLUMBIA (CA) 1989-08-16 CN claimed